go to contents

DIPHA GmbH

Back to list

Facts

Founded
2004
Staff
2
Organization type
RDM biotech/pharma
Region
Vienna

Profile

Technology transfer, pharmaceutical development for solid dosage forms (tablet, granulates, a.o.) for clinical studies, liquids and creams. Study development and monitoring (Phase I-II), CRO biomarker development for inflammatory and autoimmun diseases, product management for pharmacies, licensing and marketing

R&D:bioactive substances and metabolism formulation of APIs qualification and standardisation of bioactive substances Biomarker development for inflammatory diagnostics solid dose formulation development for synthetic and natural active ingredients, process development for natural and synthetic active ingredients,

Production:Clinical Trial Products for studies (off label use)

Services:Programm management for technology transfer, contracting and licensing of products product life cycle management product launch management clinical study design observational studies

Sales/Distribution:samples for clinical trials (dermatologics) and observational studies

Similar companies in RDM biotech/pharma

Merck Sharp & Dohme Ges.m.b.H.

Organization type
RDM biotech/pharma
Region
Vienna
Details

Panoptes Pharma Ges.m.b.H.

Organization type
RDM biotech/pharma
Region
Vienna
Details

emergentec biodevelopment GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Details

Novogenia GmbH

Organization type
RDM biotech/pharma
Region
Salzburg
Details

Contact

Sollingergasse 5/27
1190 Vienna
Vienna

Contact: Oliver Dinstl (CEO)
Telephone: +43 (664) 461089-6
Email: office@dipha.at
Website